Skip to main content
. 2019 Nov 11;11(1):107–117. doi: 10.1007/s13300-019-00723-x

Table 2.

Incidence of adverse drug reactions and serious adverse drug reactions

ADRs [n (%)] Incidence (N = 2235 patients)
Any ADRs 240 (10.7)
ADRs occurring in ≥ 5 patients
 Diabetes mellitus 35 (1.6)
 Constipation 21 (0.9)
 Diabetes mellitus inadequate control 13 (0.6)
 Hypertension 13 (0.6)
 Hyperuricemia 11 (0.5)
 Hepatic function abnormal 11 (0.5)
 Dizziness 9 (0.4)
 Decreased appetite 6 (0.3)
 Weight increased 6 (0.3)
 Gastroesophageal reflux disease 5 (0.2)
ADRs leading to discontinuation 74 (3.3)
Serious ADRs 35 (1.6)
Serious ADRs occurring in ≥ 2 patients
 Cerebral infarction 4 (0.2)
 Myocardial infarction 3 (0.1)
 Pancreatic carcinoma 3 (0.1)
 Death 3 (0.1)
 Sudden death 2 (0.1)
 Fall 2 (0.1)

ADR Adverse drug reaction